CLX
65
2
MSI
55
-2
CHD
39
2
VZ
30
5
MET
60
2
BIIB
42
2
ED
42
2
GOOG
81
-2
K
56
3
WHR
59
-2
CVS
32
3
ROST
66
4
F
42
2
CMA
48
2
PSX
29
2
LNC
32
3
D
37
2
ICE
57
2
JCI
44
2
STX
35
-2
CLX
65
2
MSI
55
-2
CHD
39
2
VZ
30
5
MET
60
2
BIIB
42
2
ED
42
2
GOOG
81
-2
K
56
3
WHR
59
-2
CVS
32
3
ROST
66
4
F
42
2
CMA
48
2
PSX
29
2
LNC
32
3
D
37
2
ICE
57
2
JCI
44
2
STX
35
-2
Financhill
Back

Grupo Financiero Banorte SAB de CV Vs. Aligos Therapeutics Industry Stock Comparison

Sell
44

GBOOY
Grupo Financiero Banorte SAB de CV

Last Price:
$33.37
Seasonality Move:
6.22%
Buy
65

ALGS
Aligos Therapeutics

Last Price:
$41.84
Seasonality Move:
-16.03%
Sell
44
Grupo Financiero Banorte SAB de CV (GBOOY) is a Sell

Is Grupo Financiero Banorte SAB de CV a Buy, Sell or Hold?

  • The current Grupo Financiero Banorte SAB de CV [GBOOY] share price is $33.83. The Score for GBOOY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • GBOOY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $43.37. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GBOOY Stock Price Chart

What is Grupo Financiero Banorte SAB de CV's stock price today?

  • The Grupo Financiero Banorte SAB de CV share price today is $33.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GBOOY is experiencing slight selling pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $43.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

GBOOY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 46.82 Sell
Chaikin Money Flow: -3524 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.34 - 35.14) Sell
Bollinger Bands (100): (33.97 - 37.27) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.71 Buy
Relative Strength Index (14 RSI): 81.52 Buy
Chaikin Money Flow: 630913 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.74 - 36.8) Buy
Bollinger Bands (100): (6.83 - 25.23) Buy

GBOOY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.95 Sell
20-day SMA: 34.27 Sell
50-day SMA: 34.97 Sell
200-day SMA: 41.07 Sell
8-day EMA: 34 Sell
20-day EMA: 34.3 Sell
50-day EMA: 34.98 Sell
200-day EMA: 39.15 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.61 Buy
20-day SMA: 32.22 Buy
50-day SMA: 20.6 Buy
200-day SMA: 16.51 Buy
8-day EMA: 38.12 Buy
20-day EMA: 32.66 Buy
50-day EMA: 24.43 Buy
200-day EMA: 18.11 Buy

Grupo Financiero Banorte SAB de CV Earnings Growth & GBOOY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and an increase next year of $0.53 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

Grupo Financiero Banorte SAB de CV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):